State of Wyoming’s Anika Therapeutics ANIK Stock Holding History

State of Wyoming’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-510	Closed	-$13K	–	1855
2022 Q1	$13K	Buy	510 +54	+12%	+$1.65K	0.01%	1559
2021 Q4	$16K	Sell	456 -4	-0.9%	-$160	0.01%	1558
2021 Q3	$20K	Buy	460 +136	+42%	+$5.6K	0.01%	940
2021 Q2	$14K	Buy	+324	New	+$13.8K	0.01%	973

Other funds holding ANIK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

State of Wyoming's ANIK Position: Q2 2022 in Review

State of Wyoming sold out of Anika Therapeutics (ANIK) in Q2 2022, closing a stake of 510 shares — an estimated $13K sold.

State of Wyoming first reported a position in ANIK in Q2 2021 and held it in 4 quarters. The position peaked at $20K in Q3 2021. 126 funds tracked by Wall St. Rank hold ANIK as of Q2 2022.

State of Wyoming reported no remaining Anika Therapeutics position as of Q2 2022 after selling out during the quarter.
State of Wyoming sold 510 Anika Therapeutics shares in Q2 2022, an estimated $13K.
State of Wyoming first reported a position in Anika Therapeutics in Q2 2021 and held it in 4 quarters.
State of Wyoming's Anika Therapeutics position peaked at $20K in Q3 2021.
126 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2022.

Based on State of Wyoming's 13F filing for Q2 2022, filed 15 Aug 2022.